Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19622257 | 0.81 | CASP3 (0.54) | CASP3KMT2A | |
| SCHEMBL30704249 | 0.81 | CASP3 (0.54) | CASP3KMT2A | |
| SCHEMBL23918186 | 0.79 | CASP3 (0.45) | CASP3KMT2APIN1PTPN1 | |
| SCHEMBL2949021 | 0.79 | CASP3 (0.49) | CASP3KMT2APTPN1 | |
| SCHEMBL13176110 | 0.78 | ITGB3 (0.62) | — | |
| SCHEMBL30945373 | 0.77 | MDM4 (0.52) | CASP3TLR2 | |
| SCHEMBL30945374 | 0.77 | MDM4 (0.52) | CASP3TLR2 | |
| SCHEMBL20356921 | 0.77 | MDM4 (0.52) | CASP3TLR2 | |
| SCHEMBL22442043 | 0.77 | MDM4 (0.52) | CASP3TLR2 | |
| SCHEMBL20356919 | 0.77 | MDM4 (0.52) | CASP3TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090285798-A1 | CD4 MIMIC PEPTIDES AND THEIR USES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090285798-A1 | CD4 MIMIC PEPTIDES AND THEIR USES | CD4, HGFAC, GZMB | CASP3 284/4885KMT2A 2095/4885PIN1 1931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.